Acetylenic compound useful in treating inflammatory disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S106000, C544S162000, C546S184000, C548S566000, C564S305000, C514S231200

Reexamination Certificate

active

07022703

ABSTRACT:
This invention is directed to acetylenic compounds as inhibitors of a nicotinamide adenine dinucleotide oxidase hydride donor useful in treating or ameliorating a reactive oxygen species mediated inflammatory disorder.

REFERENCES:
patent: 6239077 (2001-05-01), Andoh et al.
patent: 0146271 (1985-06-01), None
patent: 0171209 (1986-02-01), None
patent: 0551662 (1993-07-01), None
patent: WO 9504277 (1995-02-01), None
patent: WO 0232435 (2002-04-01), None
Biemond, P. et al., “Superoxide production by polymorphonuclear leucocytes iln rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase.”Annals of the Rheumatic Disease, 1986, pp. 249-255.
Gould, P.L. et al., “Salt selection for basic drugs,”Intl. J. Pharmaceutics, 1986, pp. 201-217.
Miesel, R. et al., “Antiinflammatory Effects of NADPH Oxidase Inhibitors,”Inflammation, 1995, pp. 347-362, vol. 19.
Miesel, R. et al., “Suppression of Inflammatory Athritis by Siimultaneous Inhibition of Nitric Oxide Synthase and NADPH Oxidase.”Free Radical Biology&Medicine, 1996, pp. 75-81, vol. 20, No. 1.
Hancock, B. C., Characteristics and Significance of the Amorphous State in Pharmaceutical Systems,J. Pharm. Sciences, 1997, pp. 1-12, vol. 86, No. 1.
Bianca, V.D. et al., “β-Amyloid Activates the O Forming NADPH Oxidase in Microglia Monocytes, and Neutrophils,”J. Bio. Chem., 1999, pp. 15493-15499, vol. 274, No. 22.
Begley, T.P. et al., “The Biosynthesis of Nicotinamide Adenine Dinucleotides in Bacteria,”Vitamins&Hormones, 2001, pp. 103-119, vol. 61.
PCT International Search Report dated Jul. 24, 2002 for PCT Appln. No. PCT/US 03/23140 which relates to U.S. Appl. No. 10/626,155.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Acetylenic compound useful in treating inflammatory disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acetylenic compound useful in treating inflammatory disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylenic compound useful in treating inflammatory disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3549630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.